Jonathan Yong
Stock Analyst at UBS
(3.29)
# 856
Out of 4,817 analysts
103
Total ratings
57.89%
Success rate
9.54%
Average return
Main Sectors:
Stocks Rated by Jonathan Yong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EHTH eHealth | Initiates: Neutral | $5.5 | $5.82 | -5.50% | 4 | Dec 4, 2024 | |
| CLOV Clover Health Investments | Initiates: Neutral | $4 | $3.38 | +18.34% | 3 | Oct 7, 2024 | |
| OSCR Oscar Health | Initiates: Neutral | $23 | $11.55 | +99.13% | 7 | Oct 7, 2024 | |
| PINC Premier | Maintains: Neutral | $33 → $25 | $19.63 | +27.36% | 2 | Aug 24, 2023 | |
| WBA Walgreens Boots Alliance | Maintains: Neutral | $33 → $30 | $10.99 | +173.10% | 5 | Aug 24, 2023 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $12 | $7.33 | +63.71% | 3 | Aug 11, 2023 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $7 → $8 | $4.46 | +79.37% | 4 | Aug 10, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $27 → $26 | $13.97 | +86.11% | 2 | Aug 8, 2023 | |
| HIMS Hims & Hers Health | Reiterates: Outperform | $14 | $25.35 | -44.77% | 3 | Aug 8, 2023 | |
| HSIC Henry Schein | Reiterates: Outperform | $96 | $64.54 | +48.74% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $29 → $32 | $15.88 | +101.51% | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $115 → $105 | $18.00 | +483.50% | 4 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $76 → $80 | $98.94 | -19.14% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $247 → $231 | $220.40 | +4.81% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $101 | $91.54 | +10.33% | 5 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $27 | $6.92 | +290.17% | 5 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $100 | $133.71 | -25.21% | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $430 → $450 | $695.17 | -35.27% | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $12 | $2.57 | +366.93% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $7.73 | +805.56% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $9.41 | +80.66% | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $347 → $350 | $321.16 | +8.98% | 3 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $95 | $20.60 | +361.17% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $7 → $8.5 | $10.73 | -20.78% | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $41 | $22.83 | +79.59% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $17 | $6.50 | +161.74% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.3 → $8.5 | $2.41 | +252.70% | 2 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $79.47 | +6.96% | 1 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $143 → $146 | $172.66 | -15.44% | 1 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $106 | $60.23 | +75.99% | 3 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $129 → $157 | $161.39 | -2.72% | 1 | Nov 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $368 | $337.07 | +9.18% | 2 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $548 → $635 | $258.71 | +145.45% | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $113 → $117 | $65.45 | +78.76% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $30 | $12.18 | +146.31% | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $267 → $298 | $324.62 | -8.20% | 1 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $114.68 | -17.16% | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $462 → $495 | $427.18 | +15.88% | 1 | Oct 15, 2021 |
eHealth
Dec 4, 2024
Initiates: Neutral
Price Target: $5.5
Current: $5.82
Upside: -5.50%
Clover Health Investments
Oct 7, 2024
Initiates: Neutral
Price Target: $4
Current: $3.38
Upside: +18.34%
Oscar Health
Oct 7, 2024
Initiates: Neutral
Price Target: $23
Current: $11.55
Upside: +99.13%
Premier
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $25
Current: $19.63
Upside: +27.36%
Walgreens Boots Alliance
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $30
Current: $10.99
Upside: +173.10%
Enhabit
Aug 11, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $7.33
Upside: +63.71%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7 → $8
Current: $4.46
Upside: +79.37%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27 → $26
Current: $13.97
Upside: +86.11%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $25.35
Upside: -44.77%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $64.54
Upside: +48.74%
Aug 7, 2023
Maintains: Neutral
Price Target: $29 → $32
Current: $15.88
Upside: +101.51%
Aug 4, 2023
Maintains: Outperform
Price Target: $115 → $105
Current: $18.00
Upside: +483.50%
Aug 4, 2023
Maintains: Outperform
Price Target: $76 → $80
Current: $98.94
Upside: -19.14%
Aug 2, 2023
Maintains: Outperform
Price Target: $247 → $231
Current: $220.40
Upside: +4.81%
Jul 27, 2023
Reiterates: Neutral
Price Target: $101
Current: $91.54
Upside: +10.33%
Jul 26, 2023
Reiterates: Neutral
Price Target: $27
Current: $6.92
Upside: +290.17%
Jun 12, 2023
Maintains: Neutral
Price Target: $90 → $100
Current: $133.71
Upside: -25.21%
May 12, 2023
Maintains: Outperform
Price Target: $430 → $450
Current: $695.17
Upside: -35.27%
May 5, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $2.57
Upside: +366.93%
May 4, 2023
Maintains: Neutral
Price Target: $80 → $70
Current: $7.73
Upside: +805.56%
Apr 28, 2023
Maintains: Neutral
Price Target: $14 → $17
Current: $9.41
Upside: +80.66%
Apr 28, 2023
Maintains: Outperform
Price Target: $347 → $350
Current: $321.16
Upside: +8.98%
Apr 28, 2023
Maintains: Outperform
Price Target: $93 → $95
Current: $20.60
Upside: +361.17%
Apr 4, 2023
Maintains: Underperform
Price Target: $7 → $8.5
Current: $10.73
Upside: -20.78%
Mar 7, 2023
Reiterates: Outperform
Price Target: $41
Current: $22.83
Upside: +79.59%
Mar 7, 2023
Maintains: Neutral
Price Target: $20 → $17
Current: $6.50
Upside: +161.74%
Feb 17, 2023
Maintains: Neutral
Price Target: $3.3 → $8.5
Current: $2.41
Upside: +252.70%
Feb 16, 2023
Reiterates: Outperform
Price Target: $85
Current: $79.47
Upside: +6.96%
Jan 25, 2023
Maintains: Neutral
Price Target: $143 → $146
Current: $172.66
Upside: -15.44%
Dec 19, 2022
Maintains: Outperform
Price Target: $104 → $106
Current: $60.23
Upside: +75.99%
Nov 25, 2022
Maintains: Outperform
Price Target: $129 → $157
Current: $161.39
Upside: -2.72%
Nov 7, 2022
Maintains: Outperform
Price Target: $329 → $368
Current: $337.07
Upside: +9.18%
Nov 3, 2022
Maintains: Outperform
Price Target: $548 → $635
Current: $258.71
Upside: +145.45%
Aug 8, 2022
Maintains: Outperform
Price Target: $113 → $117
Current: $65.45
Upside: +78.76%
May 3, 2022
Maintains: Outperform
Price Target: $31 → $30
Current: $12.18
Upside: +146.31%
Oct 25, 2021
Maintains: Outperform
Price Target: $267 → $298
Current: $324.62
Upside: -8.20%
Oct 22, 2021
Maintains: Outperform
Price Target: $88 → $95
Current: $114.68
Upside: -17.16%
Oct 15, 2021
Maintains: Outperform
Price Target: $462 → $495
Current: $427.18
Upside: +15.88%